Skip to main content
Log in or Sign up
to access My Account functionalities
Find similiar products:
-
By ATC code
My Account Area
Find similiar products:
-
By ATC code
Report side effect
Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to
site
Back to top
Boots Cough Syrup 3 Months Plus
Active Ingredient:
glycerol
Company:
THE BOOTS COMPANY PLC
See contact details
About Medicine
General Sales List
My Account Area
This information is for use by healthcare professionals
Last updated on emc: 29 Jul 2022
Quick Links
1. Name of the medicinal product
Infant Simple Cough Linctus 3 Months Plus or Infant Sugar Free Simple Cough Linctus or Children's 3 Months Plus Simple Cough Linctus or Boots Cough Syrup 3 Months Plus
2. Qualitative and quantitative composition
| Active ingredient | % v/v | ml/5ml |
| Glycerol Ph Eur | 15.0 | 0.75 |
3. Pharmaceutical form
Syrup
4. Clinical particulars
4.1 Therapeutic indications
For the relief of dry tickly coughs.
4.2 Posology and method of administration
For oral administration.
Children 3 months - 1 year: one 5ml spoonful three to four times a day.
Children 1 to 5 years: two 5ml spoonfuls three to four times a day.
Children under 3 months: not recommended.
4.3 Contraindications
Hypersensitivity to any of the ingredients.
4.4 Special warnings and precautions for use
Not recommended for children under 3 months.
If symptoms persist for more than 3 days consult your doctor.
Keep all medicines out of the reach of children.
4.5 Interaction with other medicinal products and other forms of interaction
No clinically significant drug interactions.
4.6 Pregnancy and lactation
The safety of this product during pregnancy and lactation has not been established but is not thought to constitute a hazard.
4.7 Effects on ability to drive and use machines
No adverse effects known.
4.8 Undesirable effects
Immune system disorder: hypersensitivity reactions, including anaphylaxis.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.
4.9 Overdose
Overdosage with this product may possibly cause diarrhoea. Treatment should be symptomatic.
5. Pharmacological properties
5.1 Pharmacodynamic properties
Glycerin has demulcent properties and may possibly block sensory cough receptors in the respiratory tract.
5.2 Pharmacokinetic properties
None stated.
5.3 Preclinical safety data
Not applicable
6. Pharmaceutical particulars
6.1 List of excipients
Maltitol liquid
Hydroxyethylcellulose
Sodium benzoate
Citric acid monohydrate
Sodium citrate
Apple flavouring 5112OIE
Purified water
6.2 Incompatibilities
None stated
6.3 Shelf life
36 months
6.4 Special precautions for storage
Keep tightly closed.
Do not store above 25° C.
6.5 Nature and contents of container
1) Bottle amber PET with polypropylene child resistant closure fitted with expanded polythene liner.
Pack size: 100ml and 150 ml
2) Bottle amber glass with polypropylene child resistant closure fitted with an expanded polyethylene liner.
Pack size 100, 125ml or 150ml.
6.6 Special precautions for disposal and other handling
Not applicable
7. Marketing authorisation holder
The Boots Company PLC
1 Thane Road West
Nottingham NG2 3AA
Trading as: BCM
8. Marketing authorisation number(s)
PL 00014/0500
9. Date of first authorisation/renewal of the authorisation
11/01/2007
10. Date of revision of the text
14/07/2015
Delivered to you by
